首页> 外文OA文献 >Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors

【2h】

Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors

机译：顺铂和磷脂酰肌醇3-激酶（PI3K）抑制剂在癌症生长和BRCA1突变肿瘤转移中的协同治疗作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Athanassios Vassilopoulos; Cuiying Xiao; Cristine Chisholm; Weiping Chen; Xiaoling Xu; Tyler J. Lahusen; Carole Bewley; Chu-Xia Deng;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors [J] . Athanassios Vassilopoulos, Cuiying Xiao, Cristine Chisholm, The Journal of biological chemistry . 2014,第35期

机译：顺铂和磷脂酰肌醇3-激酶（PI3K）抑制剂在癌症生长和BRCA1突变肿瘤转移中的协同治疗作用
2. A Phase I study of the dual, intravenous (IV) phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor PF-05212384 in combination with irinotecan in patients (pts) with colorectal cancer (CRC) and other advanced solid tumors [J] . Wainberg Z., Tabernero J., Maqueda M. A., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：I期研究对雷帕霉素（mTOR）抑制剂PF-05212384与伊立替康联用的双重静脉内（IV）磷脂酰肌醇3-激酶（PI3K）/哺乳动物靶点在患有结直肠癌（CRC）和其他晚期固体的患者（pts）中肿瘤
3. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway [J] . Liao Xiao-Zhong, Gao Ying, Huang Sheng, Phytotherapy research: PTR . 2019,第9期

机译：丹参酮联合顺铂同时协同抑制体外和体内非小细胞肺癌，通过下调磷脂酰肌醇3-激酶/ AKT信号通路
4. Multifaceted activities of class Ⅰ phosphatidylinositol 3-kinase inhibitor ZSTK474 on human breast cancer cells [C] . Xin Peng, Zhengming Wang, Chang Zhou, International Forum on Leading Edge Technologies on Crystallization Engineering and Pharmaceutics Development;Tianjin University;Tianjin Medical University . -1

机译：Ⅰ类磷脂酰肌醇3-激酶抑制剂ZSTK474对人乳腺癌细胞的多丝活动
5. Overcoming Anti-Estrogen Resistance in Estrogen Receptor (ER)-Positive Breast Cancer: Rational Targeting of Phosphatidylinositol 3-Kinase (PI3K) and the Resurrection of Estrogen Therapy [D] . Hosford, Sarah 2018

机译：克服雌激素受体（ER）阳性乳腺癌中的抗雌激素抵抗：磷脂酰肌醇3-激酶（PI3K）的合理靶向和雌激素疗法的复活
6. Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors [O] . Athanassios Vassilopoulos, Cuiying Xiao, Cristine Chisholm, 2014

机译：顺铂和磷脂酰肌醇3-激酶（PI3K）抑制剂在Brca1突变肿瘤的癌症生长和转移中的协同治疗作用。
7. Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics [O] . 2013

机译：磷脂酰肌醇3-激酶（PI3K）抑制剂作为癌症治疗剂

Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors

著录项

引文网络

相似文献

相关主题

期刊订阅